GLP-1 receptor agonists, initially for diabetes and weight loss, show promise in substance addiction treatment. A transformative breakthrough in healthcare.
Obesity drugs show promise in combatting substance abuse
Original Article by Lisa Jarvis | Bloomberg | 26 June 2024
GLP-1 receptor agonists, initially for diabetes and weight loss, show promise in substance addiction treatment. A transformative breakthrough in healthcare.